Last 12 months
Inside the activity.
0 purchase rows · 39 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 14 |
| Dec 2025 | 0 | 8 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 9 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2023 Filed Oct 10, 2023 21:27 UTC |
DuRoss AmyDirector
|
GrantCommon Stock | 437 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-034209 · wk-form4_1696973241.xml · nonDerivative · entry 1 DuRoss Amy · CIK 0001854968 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,781 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant. Read SEC document |
| October 01, 2023 Filed Oct 10, 2023 21:27 UTC |
Schick Joseph CDirector
|
GrantCommon Stock | 445 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-034208 · wk-form4_1696973227.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,081 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant. Read SEC document |
| October 01, 2023 Filed Oct 10, 2023 21:27 UTC |
GOSWAMI JOYDEEPDirector
|
GrantCommon Stock | 422 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-034207 · wk-form4_1696973215.xml · nonDerivative · entry 1 GOSWAMI JOYDEEP · CIK 0001533115 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,269 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant. Read SEC document |
| October 01, 2023 Filed Oct 10, 2023 21:26 UTC |
Ellingson RachelDirector
|
GrantCommon Stock | 362 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-034206 · wk-form4_1696973203.xml · nonDerivative · entry 1 Ellingson Rachel · CIK 0001557271 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,190 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant. Read SEC document |
| October 01, 2023 Filed Oct 10, 2023 21:26 UTC |
DE GREEF RODERICKDirector
|
GrantCommon Stock | 362 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-034205 · wk-form4_1696973193.xml · nonDerivative · entry 1 DE GREEF RODERICK · CIK 0001241181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,262 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant. Read SEC document |
| October 01, 2023 Filed Oct 10, 2023 21:26 UTC |
MOORE TIMOTHY L.Director
|
GrantCommon Stock | 362 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-034204 · wk-form4_1696973174.xml · nonDerivative · entry 1 MOORE TIMOTHY L. · CIK 0001669207 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,138 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant. Read SEC document |
| September 28, 2023 Filed Oct 2, 2023 21:08 UTC |
Foster Karen A.Chief Quality Officer
|
SaleCommon Stock | 568 | $14.16 | $8,042.88 |
DisclosureSEC source: 0001628280-23-033511 · wk-form4_1696280929.xml · nonDerivative · entry 2 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,767 F2 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-25-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| September 28, 2023 Filed Oct 2, 2023 21:07 UTC |
Rice MichaelDirector · Chief Executive Officer
|
SaleCommon Stock | 831 | $14.16 | $11,766.96 |
DisclosureSEC source: 0001628280-23-033507 · wk-form4_1696280818.xml · nonDerivative · entry 2 Rice Michael · CIK 0001389512 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 418,635 F2 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-25-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| September 28, 2023 Filed Oct 2, 2023 21:04 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 659 | $14.16 | $9,331.44 |
DisclosureSEC source: 0001628280-23-033504 · wk-form4_1696280655.xml · nonDerivative · entry 2 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 273,121 F2 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-25-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| September 28, 2023 Filed Oct 2, 2023 20:56 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 464 | $14.16 | $6,570.24 |
DisclosureSEC source: 0001628280-23-033496 · wk-form4_1696280188.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,014 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-25-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| September 24, 2023 Filed Oct 2, 2023 21:08 UTC |
Foster Karen A.Chief Quality Officer
|
GrantCommon Stock | 260 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-033511 · wk-form4_1696280929.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,335 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| September 24, 2023 Filed Oct 2, 2023 21:07 UTC |
Rice MichaelDirector · Chief Executive Officer
|
GrantCommon Stock | 290 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-033507 · wk-form4_1696280818.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 419,466 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| September 24, 2023 Filed Oct 2, 2023 21:04 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
GrantCommon Stock | 802 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-033504 · wk-form4_1696280655.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 273,780 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| September 24, 2023 Filed Oct 2, 2023 21:02 UTC |
Wichterman TroyChief Financial Officer
|
GrantCommon Stock | 290 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-033502 · wk-form4_1696280531.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,590 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| September 24, 2023 Filed Oct 2, 2023 20:58 UTC |
Phillips GeraintSVP, Global Operations
|
GrantCommon Stock | 221 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-033499 · wk-form4_1696280285.xml · nonDerivative · entry 1 Phillips Geraint · CIK 0001960665 · SVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,995 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| September 21, 2023 Filed Sep 25, 2023 20:57 UTC |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 539 | $12.70 | $6,845.30 |
DisclosureSEC source: 0001628280-23-032947 · wk-form4_1695675448.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,300 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 06-19-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| September 10, 2023 Filed Sep 12, 2023 20:49 UTC |
Phillips GeraintSVP, Global Operations
|
GrantCommon Stock | 328 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-032091 · wk-form4_1694551753.xml · nonDerivative · entry 1 Phillips Geraint · CIK 0001960665 · SVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,774 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| September 10, 2023 Filed Sep 12, 2023 20:48 UTC |
Wichterman TroyChief Financial Officer
|
GrantCommon Stock | 408 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-032090 · wk-form4_1694551695.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,839 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| September 10, 2023 Filed Sep 12, 2023 20:47 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
GrantCommon Stock | 792 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-032089 · wk-form4_1694551660.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,978 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| September 10, 2023 Filed Sep 12, 2023 20:47 UTC |
Rice MichaelDirector · Chief Executive Officer
|
GrantCommon Stock | 1,022 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-032088 · wk-form4_1694551634.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 419,176 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| September 10, 2023 Filed Sep 12, 2023 20:46 UTC |
Foster Karen A.Chief Quality Officer
|
GrantCommon Stock | 330 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-032087 · wk-form4_1694551604.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,075 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| August 27, 2023 Filed Aug 30, 2023 21:39 UTC |
Phillips GeraintSVP, Global Operations
|
GrantCommon Stock | 401 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-031007 · wk-form4_1693431566.xml · nonDerivative · entry 1 Phillips Geraint · CIK 0001960665 · SVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,446 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| August 27, 2023 Filed Aug 30, 2023 21:39 UTC |
Wichterman TroyChief Financial Officer
|
GrantCommon Stock | 498 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-031006 · wk-form4_1693431531.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,431 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| August 27, 2023 Filed Aug 30, 2023 21:38 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
GrantCommon Stock | 966 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-031005 · wk-form4_1693431505.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,186 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| August 27, 2023 Filed Aug 30, 2023 21:38 UTC |
Rice MichaelDirector · Chief Executive Officer
|
GrantCommon Stock | 1,248 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-031004 · wk-form4_1693431476.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 418,154 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| August 27, 2023 Filed Aug 30, 2023 21:37 UTC |
Foster Karen A.Chief Quality Officer
|
GrantCommon Stock | 403 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-031003 · wk-form4_1693431453.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,745 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| August 25, 2023 Filed Aug 29, 2023 21:54 UTC |
Schulz MarcusChief Revenue Officer
|
SaleCommon Stock | 347 | $10.99 | $3,813.53 |
DisclosureSEC source: 0001628280-23-030917 · wk-form4_1693346070.xml · nonDerivative · entry 1 Schulz Marcus · CIK 0001812702 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,097 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| August 25, 2023 Filed Aug 29, 2023 21:53 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 519 | $10.99 | $5,703.81 |
DisclosureSEC source: 0001628280-23-030916 · wk-form4_1693346023.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 271,220 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| August 25, 2023 Filed Aug 29, 2023 21:53 UTC |
Rice MichaelDirector · Chief Executive Officer
|
SaleCommon Stock | 1,729 | $10.99 | $19,001.71 |
DisclosureSEC source: 0001628280-23-030915 · wk-form4_1693345983.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 416,906 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| August 25, 2023 Filed Aug 29, 2023 21:52 UTC |
Foster Karen A.Chief Quality Officer
|
SaleCommon Stock | 410 | $10.99 | $4,505.90 |
DisclosureSEC source: 0001628280-23-030914 · wk-form4_1693345930.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,342 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| August 25, 2023 Filed Aug 29, 2023 21:51 UTC |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 585 | $10.99 | $6,429.15 |
DisclosureSEC source: 0001628280-23-030912 · wk-form4_1693345863.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,933 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| August 25, 2023 Filed Aug 29, 2023 21:50 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 347 | $10.99 | $3,813.53 |
DisclosureSEC source: 0001628280-23-030911 · wk-form4_1693345803.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,478 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| August 25, 2023 Filed Aug 29, 2023 21:49 UTC |
Phillips GeraintSVP, Global Operations
|
SaleCommon Stock | 179 | $10.99 | $1,967.21 |
DisclosureSEC source: 0001628280-23-030910 · wk-form4_1693345751.xml · nonDerivative · entry 1 Phillips Geraint · CIK 0001960665 · SVP, Global Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,045 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| August 25, 2023 Filed Aug 29, 2023 21:48 UTC |
Aebersold SarahChief Human Resources Officer
|
SaleCommon Stock | 347 | $10.99 | $3,813.53 |
DisclosureSEC source: 0001628280-23-030909 · wk-form4_1693345657.xml · nonDerivative · entry 1 Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,532 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 20:48 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 180 | $12.38 | $2,228.40 |
DisclosureSEC source: 0001628280-23-029686 · wk-form4_1692218906.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 271,739 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 20:49 UTC |
Rice MichaelDirector · Chief Executive Officer
|
SaleCommon Stock | 277 | $12.38 | $3,429.26 |
DisclosureSEC source: 0001628280-23-029688 · wk-form4_1692218968.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 418,635 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 20:49 UTC |
Schulz MarcusChief Revenue Officer
|
SaleCommon Stock | 108 | $12.38 | $1,337.04 |
DisclosureSEC source: 0001628280-23-029687 · wk-form4_1692218936.xml · nonDerivative · entry 1 Schulz Marcus · CIK 0001812702 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,444 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 20:48 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 134 | $12.38 | $1,658.92 |
DisclosureSEC source: 0001628280-23-029685 · wk-form4_1692218881.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,825 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 20:47 UTC |
Phillips GeraintSVP, Global Operations
|
SaleCommon Stock | 109 | $12.57 | $1,370.13 |
DisclosureSEC source: 0001628280-23-029684 · wk-form4_1692218854.xml · nonDerivative · entry 1 Phillips Geraint · CIK 0001960665 · SVP, Global Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,224 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 20:47 UTC |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 94 | $12.57 | $1,181.58 |
DisclosureSEC source: 0001628280-23-029683 · wk-form4_1692218830.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,518 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 20:46 UTC |
Foster Karen A.Chief Quality Officer
|
SaleCommon Stock | 156 | $12.38 | $1,931.28 |
DisclosureSEC source: 0001628280-23-029682 · wk-form4_1692218805.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,752 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 20:46 UTC |
Aebersold SarahChief Human Resources Officer
|
SaleCommon Stock | 104 | $12.38 | $1,287.52 |
DisclosureSEC source: 0001628280-23-029681 · wk-form4_1692218782.xml · nonDerivative · entry 1 Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,879 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| August 09, 2023 Filed Aug 11, 2023 21:01 UTC |
Casdin Partners Master Fund, L.P.10% owner
Casdin Capital, LLC10% owner
Casdin Partners GP, LLC10% owner
Casdin Eli10% owner
|
PurchaseCommon Stock, par value $.001 per share | 58,465 | $13.20 | $771,743.85 |
DisclosureSEC source: 0000919574-23-004543 · ownership.xml · nonDerivative · entry 1 Casdin Partners Master Fund, L.P. · CIK 0001534265 · 10% owner Casdin Capital, LLC · CIK 0001534261 · 10% owner Casdin Partners GP, LLC · CIK 0001534260 · 10% owner Casdin Eli · CIK 0001534264 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,630,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within the range of $13.1151 to $13.3998. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F2 · ownership.direct: The securities are owned directly by the Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC ("Casdin Capital"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP. Read SEC document |
| July 24, 2023 Filed Jul 26, 2023 22:09 UTC |
Schulz MarcusChief Revenue Officer
|
SaleCommon Stock | 679 | $19.50 | $13,240.50 |
DisclosureSEC source: 0001628280-23-025784 · wk-form4_1690409364.xml · nonDerivative · entry 1 Schulz Marcus · CIK 0001812702 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,552 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 07-17-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| July 24, 2023 Filed Jul 26, 2023 22:08 UTC |
Aebersold SarahChief Human Resources Officer
|
SaleCommon Stock | 462 | $19.50 | $9,009.00 |
DisclosureSEC source: 0001628280-23-025783 · wk-form4_1690409329.xml · nonDerivative · entry 1 Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,983 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 07-17-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| July 20, 2023 Filed Jul 24, 2023 20:35 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionEmployee Stock Option · Derivative | 10,000 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001628280-23-025476 · wk-form4_1690230904.xml · derivative · entry 6 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 10,000 shares Expires 2025-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| July 20, 2023 Filed Jul 24, 2023 20:35 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 10,000 | $20.07 | $200,700.00 |
DisclosureSEC source: 0001628280-23-025476 · wk-form4_1690230904.xml · nonDerivative · entry 4 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 271,919 F2 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 11-15-2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.17, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 20, 2023 Filed Jul 24, 2023 20:35 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 10,000 | $2.06 | $20,600.00 |
DisclosureSEC source: 0001628280-23-025476 · wk-form4_1690230904.xml · nonDerivative · entry 3 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 281,919 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 19, 2023 Filed Jul 24, 2023 20:35 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionEmployee Stock Option · Derivative | 10,000 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001628280-23-025476 · wk-form4_1690230904.xml · derivative · entry 5 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 10,000 shares Expires 2025-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| July 19, 2023 Filed Jul 24, 2023 20:35 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 10,000 | $20.46 | $204,600.00 |
DisclosureSEC source: 0001628280-23-025476 · wk-form4_1690230904.xml · nonDerivative · entry 2 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 271,919 F2 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 11-15-2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.24 to $20.84, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.